Impact BioMedical Inc.
IBO
$0.78
$0.3268.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.00K | 18.00K | 7.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.00K | 18.00K | 7.00K | -- | -- |
| Cost of Revenue | 422.00K | 1.00K | 11.00K | -- | -- |
| Gross Profit | -415.00K | 17.00K | -4.00K | -- | -- |
| SG&A Expenses | 275.00K | 516.00K | 676.00K | 509.00K | 591.00K |
| Depreciation & Amortization | 286.00K | 288.00K | 288.00K | 283.00K | 279.00K |
| Other Operating Expenses | 72.00K | 109.00K | 110.00K | 115.00K | 113.00K |
| Total Operating Expenses | 1.17M | 966.00K | 1.16M | 1.01M | 875.00K |
| Operating Income | -1.16M | -948.00K | -1.15M | -1.01M | -875.00K |
| Income Before Tax | 2.66M | -1.48M | -14.35M | -1.28M | -27.10M |
| Income Tax Expenses | -2.58M | -- | -- | -- | 33.00K |
| Earnings from Continuing Operations | 5.24M | -1.48M | -14.35M | -1.28M | -27.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.00K | 5.00K | 6.00K | 11.00K | 25.00K |
| Net Income | 5.25M | -1.47M | -14.35M | -1.27M | -27.11M |
| EBIT | -1.16M | -948.00K | -1.15M | -1.01M | -875.00K |
| EBITDA | -872.00K | -92.00K | -1.15M | -1.01M | -873.00K |
| EPS Basic | 0.06 | -0.12 | -1.18 | -0.11 | -2.36 |
| Normalized Basic EPS | 0.02 | -0.08 | -0.74 | -0.07 | -0.09 |
| EPS Diluted | 0.06 | -0.12 | -1.18 | -0.11 | -2.36 |
| Normalized Diluted EPS | 0.02 | -0.08 | -0.74 | -0.07 | -0.09 |
| Average Basic Shares Outstanding | 89.77M | 12.19M | 12.19M | 12.06M | 11.51M |
| Average Diluted Shares Outstanding | 89.77M | 12.19M | 12.19M | 12.06M | 11.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |